NICE is dead; long live NICE
Identifieur interne : 002761 ( Main/Exploration ); précédent : 002760; suivant : 002762NICE is dead; long live NICE
Auteurs : Krishna Chinthapalli [Royaume-Uni]Source :
- BMJ : British Medical Journal [ 0959-8138 ] ; 2013.
Descripteurs français
- Wicri :
- topic : Industrie pharmaceutique.
English descriptors
- KwdEn :
- April, Beta interferon, Better outcomes, Cancer drugs fund, Chief executive, Clinical excellence, Clinical guidelines, Commons health committee, Cost effectiveness, Cost effectiveness threshold, David haslam, Drug companies, Drug prices, Early breast cancer, Extra increase, Frank dobson, Full compliance, Guideline, Health secretary, Innovation health, Innovation scorecard, Local authorities, Multiple sclerosis risk, National institute, Parveen kumar, Patient groups, Pharmaceutical, Pharmaceutical benefits, Pharmaceutical industry, Qalys, Rawlins, Same time, Social care, Wider benefits.
- Teeft :
- April, Beta interferon, Better outcomes, Cancer drugs fund, Chief executive, Clinical excellence, Clinical guidelines, Commons health committee, Cost effectiveness, Cost effectiveness threshold, David haslam, Drug companies, Drug prices, Early breast cancer, Extra increase, Frank dobson, Full compliance, Guideline, Health secretary, Innovation health, Innovation scorecard, Local authorities, Multiple sclerosis risk, National institute, Parveen kumar, Patient groups, Pharmaceutical, Pharmaceutical benefits, Pharmaceutical industry, Qalys, Rawlins, Same time, Social care, Wider benefits.
Abstract
This month sees a new beginning for NICE, with a new chair and legal status. Krishna Chinthapalli assesses what it has achieved and the challenges it faces in the future
Url:
DOI: 10.1136/bmj.f2546
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002E54
- to stream Istex, to step Curation: 002E54
- to stream Istex, to step Checkpoint: 000313
- to stream Main, to step Merge: 002772
- to stream Main, to step Curation: 002761
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>NICE is dead; long live NICE</title>
<author wicri:is="90%"><name sortKey="Chinthapalli, Krishna" sort="Chinthapalli, Krishna" uniqKey="Chinthapalli K" first="Krishna" last="Chinthapalli">Krishna Chinthapalli</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:5EDC5EBFEFB92EB1C7E1D880CDD9D568FCBC67B8</idno>
<date when="2013" year="2013">2013</date>
<idno type="doi">10.1136/bmj.f2546</idno>
<idno type="url">https://api.istex.fr/document/5EDC5EBFEFB92EB1C7E1D880CDD9D568FCBC67B8/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002E54</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002E54</idno>
<idno type="wicri:Area/Istex/Curation">002E54</idno>
<idno type="wicri:Area/Istex/Checkpoint">000313</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000313</idno>
<idno type="wicri:doubleKey">0959-8138:2013:Chinthapalli K:nice:is:dead</idno>
<idno type="wicri:Area/Main/Merge">002772</idno>
<idno type="wicri:Area/Main/Curation">002761</idno>
<idno type="wicri:Area/Main/Exploration">002761</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a">NICE is dead; long live NICE</title>
<author wicri:is="90%"><name sortKey="Chinthapalli, Krishna" sort="Chinthapalli, Krishna" uniqKey="Chinthapalli K" first="Krishna" last="Chinthapalli">Krishna Chinthapalli</name>
<affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>1BMJ, London WC1H 9JR</wicri:regionArea>
<wicri:noRegion>London WC1H 9JR</wicri:noRegion>
</affiliation>
<affiliation></affiliation>
<affiliation></affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">BMJ : British Medical Journal</title>
<title level="j" type="abbrev">BMJ</title>
<idno type="ISSN">0959-8138</idno>
<idno type="eISSN">1756-1833</idno>
<imprint><publisher>British Medical Journal Publishing Group</publisher>
<date type="published" when="2013">2013</date>
<biblScope unit="volume">346</biblScope>
</imprint>
<idno type="ISSN">0959-8138</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0959-8138</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>April</term>
<term>Beta interferon</term>
<term>Better outcomes</term>
<term>Cancer drugs fund</term>
<term>Chief executive</term>
<term>Clinical excellence</term>
<term>Clinical guidelines</term>
<term>Commons health committee</term>
<term>Cost effectiveness</term>
<term>Cost effectiveness threshold</term>
<term>David haslam</term>
<term>Drug companies</term>
<term>Drug prices</term>
<term>Early breast cancer</term>
<term>Extra increase</term>
<term>Frank dobson</term>
<term>Full compliance</term>
<term>Guideline</term>
<term>Health secretary</term>
<term>Innovation health</term>
<term>Innovation scorecard</term>
<term>Local authorities</term>
<term>Multiple sclerosis risk</term>
<term>National institute</term>
<term>Parveen kumar</term>
<term>Patient groups</term>
<term>Pharmaceutical</term>
<term>Pharmaceutical benefits</term>
<term>Pharmaceutical industry</term>
<term>Qalys</term>
<term>Rawlins</term>
<term>Same time</term>
<term>Social care</term>
<term>Wider benefits</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>April</term>
<term>Beta interferon</term>
<term>Better outcomes</term>
<term>Cancer drugs fund</term>
<term>Chief executive</term>
<term>Clinical excellence</term>
<term>Clinical guidelines</term>
<term>Commons health committee</term>
<term>Cost effectiveness</term>
<term>Cost effectiveness threshold</term>
<term>David haslam</term>
<term>Drug companies</term>
<term>Drug prices</term>
<term>Early breast cancer</term>
<term>Extra increase</term>
<term>Frank dobson</term>
<term>Full compliance</term>
<term>Guideline</term>
<term>Health secretary</term>
<term>Innovation health</term>
<term>Innovation scorecard</term>
<term>Local authorities</term>
<term>Multiple sclerosis risk</term>
<term>National institute</term>
<term>Parveen kumar</term>
<term>Patient groups</term>
<term>Pharmaceutical</term>
<term>Pharmaceutical benefits</term>
<term>Pharmaceutical industry</term>
<term>Qalys</term>
<term>Rawlins</term>
<term>Same time</term>
<term>Social care</term>
<term>Wider benefits</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Industrie pharmaceutique</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract">This month sees a new beginning for NICE, with a new chair and legal status. Krishna Chinthapalli assesses what it has achieved and the challenges it faces in the future</div>
</front>
</TEI>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
</list>
<tree><country name="Royaume-Uni"><noRegion><name sortKey="Chinthapalli, Krishna" sort="Chinthapalli, Krishna" uniqKey="Chinthapalli K" first="Krishna" last="Chinthapalli">Krishna Chinthapalli</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002761 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002761 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= EdenteV2 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:5EDC5EBFEFB92EB1C7E1D880CDD9D568FCBC67B8 |texte= NICE is dead; long live NICE }}
This area was generated with Dilib version V0.6.32. |